blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0752866

EP0752866 - MEDICAMENTS FOR TREATING RESTENOSIS, COMPRISING NITRIC OXIDE RELEASING POLYMERS [Right-click to bookmark this link]
Former [1997/03]USE OF NITRIC OXIDE-RELEASING POLYMERS TO TREAT RESTENOSIS AND RELATED DISORDERS
[2001/25]
StatusNo opposition filed within time limit
Status updated on  15.04.2003
Database last updated on 19.10.2024
Most recent event   Tooltip15.04.2003No opposition filed within time limitpublished on 28.05.2003  [2003/22]
Applicant(s)For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT
Bethesda, MD 20892-9902 / US
For all designated states
COMEDICUS, INC.
3050 Jamestown Road
Long Lake, MN 55356 / US
[N/P]
Former [1997/03]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT
Bethesda, MD 20892-9902 / US
For all designated states
COMEDICUS, INC.
3050 Jamestown Road
Long Lake, MN 55356 / US
Inventor(s)01 / KEEFER, Larry, K.
7016 River Road
Bethesda, MD 20817 / US
02 / HUTSELL, Thomas, C.
26 Farm Spring Lane
North Oaks, MN 55127 / US
[1997/03]
Representative(s)Brewster, Andrea Ruth
Mewburn Ellis LLP
33 Gutter Lane
London EC2V 8AS / GB
[N/P]
Former [1997/03]Brewster, Andrea Ruth
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date95912871.109.03.1995
[1997/03]
WO1995US03040
Priority number, dateUS1994021437217.03.1994         Original published format: US 214372
[1997/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9524908
Date:21.09.1995
Language:EN
[1995/40]
Type: A1 Application with search report 
No.:EP0752866
Date:15.01.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 21.09.1995 takes the place of the publication of the European patent application.
[1997/03]
Type: B1 Patent specification 
No.:EP0752866
Date:05.06.2002
Language:EN
[2002/23]
Search report(s)International search report - published on:EP21.09.1995
ClassificationIPC:A61K31/785
[1997/03]
CPC:
A61K31/655 (EP,US); A61K31/785 (EP,US); A61K47/58 (EP,US);
A61K47/59 (EP,US); A61K47/60 (EP,US); A61K47/64 (EP,US);
A61P9/08 (EP); C08F8/32 (EP,US) (-)
C-Set:
C08F8/32, C08F8/24, C08F112/08 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/03]
TitleGerman:MEDIKAMENTE ZUR BEHANDLUNG VON RESTENOSIS, ENTHALTEND STICKSTOFF FREISETZENDE POLYMERE[2001/25]
English:MEDICAMENTS FOR TREATING RESTENOSIS, COMPRISING NITRIC OXIDE RELEASING POLYMERS[2001/25]
French:MEDICAMENTS RENFERMANT DES POLYMERES LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DE LA RESTENOSE[2001/25]
Former [1997/03]VERWENDUNG VON STICKSTOFFREISETZENDE POLYMÄRE ZUR BEHANDLUNG VON RESTENOSIS
Former [1997/03]USE OF NITRIC OXIDE-RELEASING POLYMERS TO TREAT RESTENOSIS AND RELATED DISORDERS
Former [1997/03]UTILISATION DE POLYMERES LIBERANT DE L'ACIDE NITRIQUE DANS LE BUT DE TRAITER LA RESTENOSE ET DES MALADIES APPARENTEES
Entry into regional phase17.10.1996National basic fee paid 
17.10.1996Designation fee(s) paid 
17.10.1996Examination fee paid 
Examination procedure29.09.1995Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.10.1996Examination requested  [1997/03]
06.06.2001Despatch of communication of intention to grant (Approval: No)
15.11.2001Despatch of communication of intention to grant (Approval: later approval)
23.11.2001Communication of intention to grant the patent
12.02.2002Fee for grant paid
12.02.2002Fee for publishing/printing paid
Opposition(s)06.03.2003No opposition filed within time limit [2003/22]
Fees paidRenewal fee
12.03.1997Renewal fee patent year 03
23.02.1998Renewal fee patent year 04
22.02.1999Renewal fee patent year 05
21.02.2000Renewal fee patent year 06
21.02.2001Renewal fee patent year 07
22.03.2002Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]US4954526  (KEEFER LARRY K [US]);
 [DA]US5039705  (KEEFER LARRY K [US], et al);
 [DA]US5155137  (KEEFER LARRY K [US], et al);
 [DA]US5208233  (KEEFER LARRY K [US], et al);
 [DA]US5212204  (KEEFER LARRY K [US], et al);
 [DA]US5250550  (KEEFER LARRY K [US], et al)
 [DA]  - C.M. MARAGOS ET AL., "Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects.", J. MED. CHEM., vol. 34, no. 11, pages 3242 - 3247
 [A]  - C.M. MARAGOS ET AL., "nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release.", CANCER RES., vol. 53, no. 3, pages 564 - 568
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.